Kardigan
Hector Rodriguez is a seasoned professional with extensive experience in biochemistry and biology, currently serving as the Vice President of New Targets at Kardigan since February 2025. Prior roles include Vice President of Biology at BridgeBio from July 2017 to January 2025, and Senior Director of Biology at MyoKardia from July 2012 to April 2017. Serving as a Scientific Consultant at Edgewise Therapeutics since May 2017, Hector has also established foundational groups and infrastructure at Calithera Biosciences and Arresto BioSciences. Earlier career highlights include managing protein production at Cytokinetics, Inc. and completing a Ph.D. in Chemistry at the University of California, Santa Cruz, where graduate studies were conducted under Dr. Lydia M.
This person is not in any teams
This person is not in any offices
Kardigan
Kardigan is a patient-driven heart health company that is modernizing cardiovascular drug development to deliver medicines that move patients beyond symptom management to functional cures. By matching critical disease drivers with treatment responders identified in clinical trials, Kardigan is developing a portfolio of medicines that modify the underlying cardiovascular disease pathophysiology to get patients closer to the cures they deserve. For more information about Kardigan, please visit kardigan.bio. If you are interested in joining our passionate and driven team with deep cardiovascular, biotechnology and operational expertise, please visit kardigan.bio or the careers tab of this page.